PHARMACOTHERAPY FOLLOW-UP AND CONCILIATION OF MEDICATION IN HOSPITALIZED HIP-FRACTURE PATIENTS

被引:0
|
作者
Venegas Karen, Rojo [1 ]
Padial Pilar, Aznarte
Miguel Angel, Calleja Hernandez
Ortega Carlos, Contreras [2 ]
Jose Luis, Martinez Montes
机构
[1] Univ Granada, Virgen Nieves Univ Hosp, E-18071 Granada, Spain
[2] N Catholic Univ, Santiago, Chile
来源
ATENCION FARMACEUTICA | 2009年 / 11卷 / 04期
关键词
HIP FRACTURE; NEGATIVE OUTCOMES ASSOCIATED WITH MEDICATION PHARMACOTHERAPY FOLLOW-UP; PHARMACEUTICAL INTERVENTIONS; ELDERLY-PATIENTS; MORTALITY; INTERVENTIONS; PHARMACISTS; SCORE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the pharmacotherapy follow-up (PTF) of elderly hospitalized hip fracture (HF) patients for the detection and resolution of negative medication-associated outcomes (NOM), recording their association with hospital stay. Method: Quasi-experimental prospective 4-month study of patients aged > 64 yrs. All patients underwent PTF. Study variables included age, sex, hospital stay, surgery delay, pharmaceutical interventions (PI), NOM, PI acceptance and resolution. Results: The study included 87 patients (77% females). Length of hospital stay was 13.8 days; 75% waited for Surgery < 5 days. PI were issued for 88.5% of patients; out of 215 PI (2.8/patient), 60.5% were received by physicians. NOM were prevented by 43.7% of accepted PI and resolved 56.3%. NOM were for "necessity" in 51.2%. In-hospital mortality was 12%. Conclusion: This PTF programme detected elevated NOM and NOM risk in HF patients, associated with longer hospital stay. The pharmacist conciliated medications to prevent or resolve all detected NOM.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 50 条
  • [31] EVALUATION OF PSYCHIATRIC TREATMENTS IN HOSPITALIZED PATIENTS - FOLLOW-UP STUDY
    SLUZKI, CE
    FIORINI, HJ
    ACTA PSIQUIATRICA Y PSICOLOGICA DE AMERICA LATINA, 1973, 19 (02) : 87 - 99
  • [32] Functional Outcomes of Patients with Schizophrenia After Hip Fracture Surgery A 1-Year Follow-up from an Institutional Hip Fracture Registry
    Ng, Julia Poh Hwee
    Ho, Sean Wei Loong
    Yam, Michael Gui Jie
    Tan, Tong Leng
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2021, 103 (09): : 786 - 794
  • [33] VALIDATION OF A METHODOLOGY FOR INPATIENT PHARMACOTHERAPY FOLLOW-UP
    Becerra C, Jesus
    Martinez M, Fernando
    Bohorquez C, Martha
    Guevara U, Martha
    Ramirez N, Edgar
    VITAE-REVISTA DE LA FACULTAD DE QUIMICA FARMACEUTICA, 2012, 19 (03): : 261 - 269
  • [34] FOLLOW-UP STUDY OF HOSPITALIZED ADOLESCENTS
    KIVOWITZ, J
    FORGOTSON, J
    GOLDSTEIN, G
    GOTTLIEB, F
    COMPREHENSIVE PSYCHIATRY, 1974, 15 (01) : 35 - 42
  • [35] Mortality and predictors of mortality in Finnish hip fracture patients: A 4-year follow-up study
    Salminen, M.
    Nordling, P.
    Strandberg, M.
    Strandberg, N.
    Vahlberg, T.
    Immonen-Raiha, P.
    Airaksinen, J.
    EUROPEAN GERIATRIC MEDICINE, 2016, 7 (06) : 506 - 507
  • [36] Functional recovery after hip fracture: Six months' follow-up of patients in a multidisciplinary rehabilitation program
    Dai, YT
    Huang, GS
    Yang, RS
    Tsauo, JY
    Yang, LH
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (12) : 846 - 853
  • [37] Hip fracture in hospitalized medical patients
    Zapatero, Antonio
    Barba, Raquel
    Canora, Jesus
    Losa, Juan E.
    Plaza, Susana
    San Roman, Jesus
    Marco, Javier
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [38] Hip fracture in hospitalized medical patients
    Antonio Zapatero
    Raquel Barba
    Jesús Canora
    Juan E Losa
    Susana Plaza
    Jesús San Roman
    Javier Marco
    BMC Musculoskeletal Disorders, 14
  • [39] Mortality and cause of death postoperatively in patients with a hip fracture A NATIONAL COHORT LONGITUDINAL FOLLOW-UP STUDY
    Choi, H. G.
    Lee, Y. B.
    Rhyu, S. H.
    Kwon, B. C.
    Lee, J. K.
    BONE & JOINT JOURNAL, 2018, 100B (04): : 436 - 442
  • [40] Development of a medication review with follow-up guide on patients with epilepsy
    Torralba Fernandez, Laura
    Amador Fernandez, Noelia
    ARS PHARMACEUTICA, 2019, 60 (01) : 35 - 40